Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose IV Ketamine for Adolescents with Depression and Suicidal Ideation
NCT05217706Phase 1Unknown
- Sponsor
- Rady Children’s Hospital-San Diego
- Start
- Mar 2022
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in treatment-resistant depression (TRD) and suicidal ideation comparing Ketamine with Placebo (2 arms). Primary endpoint: Change in Beck Depression Inventory Depression sub-scale Score at 7 days. Status: unknown.
02
Drugs
ketamine
03
Conditions
treatment-resistant depression (TRD)suicidal ideation
Beyond the preview
Go deeper on NCT05217706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05217706.